Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy and Sargramostim for Lung Cancer
NCT00514215Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Jan 2006
- Primary completion
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in non-small cell lung cancer (NSCLC), metastatic cancer, sponsored by Barbara Ann Karmanos Cancer Institute. Started Jan 2006; status: completed.
02
Drugs
sargramostim
03
Conditions
non-small cell lung cancer (NSCLC)metastatic cancer
Beyond the preview
Go deeper on NCT00514215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514215.